Exploring the Value of BRD9 as a Biomarker, Therapeutic Target and Co-Target in Prostate Cancer.
Nafisa BarmaTimothy C StoneLina Maria Carmona EcheverriaSusan HeaveyPublished in: Biomolecules (2021)
in vitro and in vivo, to build on the limited inhibition data available.